This note presents selected findings based on the set of well-being indicators published in How's Life? 2020.

The tax wedge for the average single worker in the Czech Republic increased by 0.1 percentage points from 43.8 in 2018 to 43.9 in 2019. The OECD average tax wedge in 2019 was 36.0 (2018, 36.1). In 2019 the Czech Republic had the 7th highest tax wedge among the 36 OECD member countries, occupying the same position in 2018.

An overview of the long-term care situation in the Slovak Republic is available here.

An overview of the long-term care situation in Mexico is available here.

An overview of the long-term care situation in the Czech Republic is available here.

Health spending continues to rise faster than economic growth in most OECD countries, maintaining a trend observed since the 1970s. Health spending reached 9.5% of GDP on average in 2009, the most recent year for which figures are available, up from 8.8% in 2008, according to OECD Health Data 2011.

Though overall medical care is improving, efforts to prevent and better manage chronic diseases such as diabetes and asthma would improve results and lower costs, according to the OECD’s latest edition of Health at a Glance.

The obesity epidemic slowed down in several OECD countries during the past three years. Rates grew less that previously projected, or did not grow at all, according to new data from ten OECD countries. However, rates remain high and social disparities in obesity are unabated.

Though the rate of public spending on healthcare in the Asia/Pacific region is still well below the OECD average, countries there are committing more resources to improving health care quality.

OECD Health Working Papers No. 60: Health Spending Growth at Zero: Which Countries, Which Sectors Are Most Affected?

Increasingly complex and inconsistent clinical trial regulations are causing delays, raising costs and leading to a decline in the number of international trials conducted by academics for non-commerical purposes.

This paper provides new projections of public spending on health and long-term care for OECD countries and the BRIICS countries (Brazil, Russia, India, Indonesia, China and South Africa). Despite the inevitable uncertainty surrounding projections, they suggest a rapidly rising trend over the next 50 years.

This report presents the findings of a research project to investigate the drivers and criteria shaping the application of genomic biotechnology to health in different national settings, and the barriers to implementation nationally and internationally. Findings are based on case studies on Finland, Israel, Luxembourg, Mexico, the United Kingdom, China and South Africa.

The future of public health: policy decisions today for tomorrow’s populations. Our health, our economy, our society, our future: a Brave New World. Remarks by Yves Leterme, Deputy Secretary-General, OECD. Brussels, Belgium, September 4th 2013.

This document outlines the methodologies and tools currently used to assess the risk of chemicals to children’s health and also identifies possible needs for additional guidance or tools based on the results of an on-line survey conducted in November 2011. The following areas of risk assessment are covered: definitions, hazard and exposure assessment, risk characterisation, cohort studies and combined exposure to multiple chemicals.

The future sustainability of health systems will depend on how well governments are able to anticipate and respond to efficiency and quality of care challenges. Bold action is required, as well as willingness to test innovative care delivery approaches. This book examines the whole new world of possibilities in using mobiles and the Internet to address healthcare challenges.

This paper explores the development of the bioplastics sector and its role in national bioeconomy strategies. It finds that bioplastics are at a disadvantage compared to some other biobased products, notably biofuels, that often benefit from preferential treatment. It also notes that greater efforts are needed at the international level as regards standards to avoid creating barriers to international trade in biobased products.

Earlier detection and better treatment for cancer would cut death rates from the disease by around a third, saving the lives of nearly a million people in the developed world every year, according to a new report by the OECD prepared with the support of the European Commission, building on earlier World Health Organisation research.

Japan has good health outcomes and has rapidly increased its spending on health care in recent years. It now needs to focus on improving efficiency of its health system in order to continue delivering high-quality care while containing costs, according to a new OECD report.

Mexico needs serious investment in prevention programmes to address its massive, and still rising, obesity rate, according to a new OECD report.

An ageing population brings new challenges both to healthcare systems and to medicine in terms of the increased manifestation of specific diseases primarily seen in the elderly. Biomedical innovation, and in particular research into "omics technologies", offers the promise of new means of detection, prevention and treatment of age-related disabilities and diseases.

Synthetic biology is an emerging technology that shows promise for investigating some of the burning issues in biological research. It also has the potential to address some of the grand challenges facing society, such as climate change and energy security.

The pricing of specialist and hospital services is a contentious issue in South Africa. To help inform domestic debates, the OECD Secretariat has produced a paper profiling international experiences on the pricing of specialist medical services services, competition policy and models of buying services from the private sector.

Strengthening primary health care and prevention programmes would help stem the growing tide of diabetes and other chronic health conditions in the Czech Republic, according to a new OECD report.

The USA has exceptional levels of health-care expenditure, but growth slowed dramatically in recent years, amidst major efforts to close the coverage gap with other OECD countries.

Several OECD countries have published their plans for the development of a future bioeconomy, in which bio-based materials and production techniques will contribute significantly to economic and environmental sustainability. The case for support for bio-based chemicals and plastics therefore warrants serious attention.

Elderly individuals with complex, chronic diseases need continuous and tailored care to maintain their health and maximise their ability to participate in society. Japan must change the way it delivers health services for older citizens by strengthening its specialist primary care and making mental health care services more widely available, according to a new OECD report.

Improving labour market participation of people with mental health problems requires well-integrated policies and services across the education, employment, health and social sectors. This paper provides examples of policy initiatives from 10 OECD countries for integrated services.

Countries in the Asia/Pacific region need to step up their efforts to give more people access to affordable, quality health care. Too many people, especially women, cannot get the medical treatment they need due to high costs, difficulties in getting permission to see a doctor or a lack of health care providers in rural areas, according to a new OECD report.

Dementia is increasing in prevalence, and to date has no cure or treatment. One element in improving this situation is using and sharing data more widely to increase the power of research. Further, moving beyond established medical data into big data offers the potential to tap into routinely collected data from both within and outside the health system.

Specific country notes have been prepared using data from the database OECD Health Statistics 2015, July 2015 version. The notes are available in PDF format.

Too many lives are still lost in OECD countries because healthcare quality is improving too slowly to cope with ageing populations and the growing number of people with one or more chronic diseases, according to a new OECD report.

In the ten years since the introduction of Seguro Popular, some 50 million Mexicans previously at risk of unaffordable health care bills now have access to health insurance. The OECD Review of Health Systems: Mexico 2016 finds that the share of the population exposed to unaffordable or impoverishing health care costs has fallen from 3.3% to 0.8% of the population in the past decade.

The Australian health system is a complex mix of federal and state government funding and responsibility, making it difficult for patients to navigate. Despite its complexity, Australia’s universal health system achieves good results relatively efficiently.

The growth rate in health spending per capita in Canada has slowed down markedly in recent years, being close to zero in real terms since 2011. Life expectancy in Canada is one year higher than the OECD average, but rising alcohol consumption and obesity rates are growing risk factors to health. Canada could further improve the quality of care in order to cope better with rising prevalence of chronic diseases.

Finland appears to have a high performing health system, with remarkable good quality in both primary and hospital care. The country also achieves good health status at relatively low level of health spending. Despite these advances, there are specific areas where improvements can be made such as preventing the spread of obesity and addressing gaps in mental health.

The French health care system performs relatively well. Health outcomes are better than the OECD average and citizens enjoy good access to care. However, France is lagging behind other OECD countries in some areas including for example antibiotics prescribing or alcohol consumption.

Italy’s indicators of health system outcomes and quality are consistently good. This is despite levels of health spending below other high-income OECD countries. However, Italy is lagging behind in some areas, like long-term care and prevention of non-communicable diseases.

Price levels for private hospital services in South Africa are comparable to the levels observed across OECD countries. But they are higher than what could be expected given the country’s income, according to a new OECD working paper.

Although Ireland has seen remarkable improvements in the health of its population in the last decades, several challenges lie ahead for its health system. Based on available OECD analyses, further progress could be made to promote efficient use of hospital resources, strengthen primary care, address high pharmaceutical spending and prevent the spread of risk factors including obesity and alcohol consumption.

Despite achieving near universal health coverage with a basic benefit package that all health payers must provide, health financing in Chile remains inefficient and inequitable. There is room for improving the system by moving towards a unified, equitable social security system for the entire population.

Although many health indicators are improving in Mexico, the country has the lowest life expectancy in the OECD. This is due to unhealthy lifestyles with higher risk factors to health leading to chronic diseases and mortality, but also to persisting barriers of access to high-quality health care services.

Belgium shows average health outcomes compared to other OECD countries. Life expectancy at birth is 80.7 years, just above the OECD average. Quality of care is fair, standing again near the OECD average. Health expenditure at 10.2% of GDP is higher than the OECD average of 1.3% points in 2013. Health policy in Belgium relies on shared responsibility of both the federal authorities and federated entities (regions and communities).

This paper looks at recent trends in pharmaceutical spending across OECD countries. It examines the drivers of recent spending trends, highlighting differences across therapeutic classes, and then looks at emerging challenges for policy makers in the management of pharmaceutical spending.

Between 2009 and 2013, public spending on health fell by EUR 5.2 billion – representing a 32% drop in real-terms. This reduction clearly represents a shock for the system to adsorb, even though it is clear that there were inefficiencies in the Greek system (for example, inappropriate prescribing, weak primary care, imbalances in the mix of health professionals).

Norway has an impressive and comprehensive health system, but it is facing several challenges over the coming years. The shift in the need for care from an ageing population will weigh heavily on the Norwegian health care system, demanding for more skilled health care personnel as well as strengthening of community care.

Israel has built a universal health system at relatively low-cost. Health spending was 7.5% of GDP in 2013, below the OECD average of 8.9% although the health spending share of GDP has been increasing rapidly, particularly in recent years. Israel has developed a sophisticated programme to monitor quality of primary care.

In the past 30 years Korea has gone from having a limited medical infrastructure, fragmented financing and limited population coverage, to a health care system characterised by universal coverage, one of the highest life expectancies in the world while still having one of the lowest levels of health expenditure among OECD countries.

At the OECD, we have calculated that about 50% of all the antimicrobials prescribed by healthcare facilities in our member countries do not meet prescription guidelines. In healthcare services such as long-term care facilities and general practices up to 70% and 90% respectively of antibiotics may be prescribed for inappropriate reasons.

Responses from the third wave of the OECD Health System Characteristics Survey are available online, providing access to the most recent information on key institutional characteristics of health systems of OECD countries and key partner and accession countries.